Amsterdam has been named the new home of the European Medicines Agency (EMA) with the agency relocating from its current London base.
The EMA has been at its London base since it was established back in 1995. The move is a direct result of the UK pulling out of the European Union, the Agency said.
It will now begin “working immediately” with the Dutch government to ensure a smooth and successful move slated for the end of March 2019.
Though the EMA had nothing to do with the selection process, Executive Director Guido Rasi seems to be satisfied with the decision.
“We welcome today’s decision on the new location of EMA,” he said. “Now that we finally know where our journey is taking us, we can take concrete actions for a successful move.”
“Amsterdam ticks many of our boxes. It offers excellent connectivity and a building that can be shaped according to our needs.
“I am very grateful that the Member States took into account our requirements for business continuity and gave priority to the protection of public and animal health.”